According to Veru's latest financial reports the company's current EPS (TTM) is -$1.38. In 2022 the company made an earnings per share (EPS) of -$1.43 a decrease over its 2021 EPS that were of -$0.20.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.38 | -3.5% |
2022 | -$1.43 | 615% |
2021 | -$0.20 | -1100% |
2020 | $0.02000 | -110% |
2019 | -$0.20 | -48.72% |
2018 | -$0.39 | 34.48% |
2017 | -$0.29 | 268.13% |
2016 | -$0.07878 | -146.34% |
2015 | $0.17 | 183.33% |
2014 | $0.06000 | -86.36% |
2013 | $0.44 | -22.81% |
2012 | $0.57 | 96.55% |
2011 | $0.29 | 3.57% |
2010 | $0.28 | 75% |
2009 | $0.16 | -20% |
2008 | $0.20 | 122.22% |
2007 | $0.09000 | |
2006 | N/A | -100% |
2005 | -$0.02000 | -85.71% |
2004 | -$0.14 | 7.69% |
2003 | -$0.13 | -43.7% |
2002 | -$0.23 | 229.86% |
2001 | -$0.07000 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.27 | -80.43% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$1.00 | -27.54% | ๐บ๐ธ USA |